ADVICENNE

Since its founding in 2007, Advicenne has been dedicated to developing and commercializing innovative treatments that address unmet medical needs in the area of nephrology. Our lead drug candidate, ADV7103, is in late-stage clinical trials for two indications: distal renal tubular acidosis (dRTA) and cystinuria. Listed on both the Euronext Paris and Euronext Brussels stock exchanges, the company is headquartered in Nîmes, France.

ADVICENNE

Social Links:

Industry:

Biotechnology Medical Pharmaceutical Therapeutics

Founded:

2007-01-01

Address:

Nîmes, Languedoc-Roussillon, France

Country:

France

Website Url:

http://www.advicenne.com

Total Employee:

11+

Status:

Active

Contact:

+33619202950

Email Addresses:

[email protected]

Total Funding:

25.4 M EUR

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress

Similar Organizations

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.

Current Employees Featured

paul-michalet_image

Paul Michalet
Paul Michalet CFO @ Advicenne
CFO
2018-09-01

didier-laurens_image

Didier Laurens
Didier Laurens CEO @ Advicenne
CEO
2021-07-01

Founder

caroline-roussel-maupetit_image

Caroline Roussel-Maupetit

luc-andre-granier_image

Luc Andre Granier

Stock Details

Company's stock symbol is EPA:ADVIC

Investors List

irdi-midi-pyrenees_image

Official Site Inspections

http://www.advicenne.com Semrush global rank: 4.62 M Semrush visits lastest month: 2.17 K

Host Informations
Whois Informations

Loading ...